HIGHLIGHTS
- who: Anthony Sebba from the (UNIVERSITY) have published the research work: Comparative effectiveness of TNF inhibitor vs IL-6 receptor inhibitor as monotherapy or combination therapy with methotrexate in biologic-experienced patients with rheumatoid arthritis: An analysis from the CorEvitas RA Registry, in the Journal: (JOURNAL)
- what: The aim of the study was to compare the effectiveness of second- and third-line TNFi vs IL-6Ri (as mono- or combination therapy) in treating RA patients with moderate or high disease activity. The study was conducted in accordance with the Declaration of Helsinki, and all participating . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.